title: Pseudotumoral recto-sigmoid herpes simplex virus type 2 in an HIV-infected patient: Dramatic improvement with thalidomide.
authors.affiliation: Service de Médecine Interne, Institut Mutualiste Montsouris, Paris, France. Electronic address: pierre.charles@imm.fr.
authors.forename: Pierre
authors.initials: P
authors.lastname: Charles
authors.affiliation: Service de Médecine Interne, Institut Mutualiste Montsouris, Paris, France.
authors.forename: Clémence
authors.initials: C
authors.lastname: Richaud
authors.affiliation: Service d'Urologie, Clinique Turin, Paris, France.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Beley
authors.affiliation: Service de Médecine Interne, Institut Mutualiste Montsouris, Paris, France.
authors.forename: Loïc
authors.initials: L
authors.lastname: Bodard
authors.affiliation: Service de Gastro-entérologie, Institut Mutualiste Montsouris, Paris, France.
authors.forename: Marion
authors.initials: M
authors.lastname: Simon
mesh_terms: D000328:Adult; D005260:Female; D006104:Granuloma, Plasma Cell / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000821:virology; D015658:HIV Infections / Q000150:complications*; D006558:Herpes Genitalis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D018258:Herpesvirus 2, Human / Q000302:isolation & purification*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D011349:Proctitis / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000821:virology; D013792:Thalidomide / Q000008:administration & dosage*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide
keywords: HIV; HSV-2; Pseudotumoral; Thalidomide